CapsoVision, Inc Net Fee Amt
CapsoVision, Inc (CV) had Net Fee Amt of $34.52 thousand as of 2026-08-10, per its S-3 filed 2026-08-13.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-08-13
- 2026-08-10: Net Fee Amt $34.52K.
- 2026-04-17: Net Fee Amt $2.43K.
| Period end | Net Fee Amt |
|---|---|
| 2026-08-10 | $34.52K S-3 · filed 2026-08-13 |
| 2026-04-17 | $2.43K S-1 · filed 2026-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |